TruBridge, Inc. (TBRG)
(Delayed Data from NSDQ)
$12.26 USD
+0.05 (0.41%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $12.26 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
B Value B Growth C Momentum B VGM
TruBridge (TBRG) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$11.80 | $14.00 | $10.00 | -3.36% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for TruBridge comes to $11.80. The forecasts range from a low of $10.00 to a high of $14.00. The average price target represents a decline of 3.36% from the last closing price of $12.21.
Analyst Price Targets (5 )
Broker Rating
TruBridge currently has an average brokerage recommendation (ABR) of 2.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.40 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, one is Strong Buy and one is Buy. Strong Buy and Buy each account for 20% of all recommendations. A month ago, Strong Buy made up 20%, while Buy represented 20%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/TBRG.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/13/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/12/2024 | Not Identified | Not Identified | Hold | Hold |
8/9/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
10/18/2023 | Stephens | Jeffrey Garro | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.40 |
ABR (Last week) | 2.40 |
# of Recs in ABR | 5 |
Average Target Price | $11.80 |
LT Growth Rate | 7.70% |
Industry | Medical Info Systems |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | 0.52 |